Type 2 Diabetes in Australia: Determinants and Interventions
This paper examines type 2 diabetes as a major and rapidly growing chronic health issue in Australia, drawing primarily on data from the AusDiab Study cohort. It identifies and evaluates key modifiable risk factors—including abdominal obesity, poor diet quality, and metabolic syndrome—and discusses how these factors interact to elevate disease risk. The paper then assesses the effectiveness of two categories of intervention: lifestyle modifications (weight loss, physical activity, and dietary change) and pharmacist-led medication compliance programs. Evidence suggests that while lifestyle interventions show modest improvements in weight and waist circumference, medication adherence supported by community pharmacy programs produces more consistent reductions in blood glucose and lipid markers among established diabetes patients.
- Introduction: Diabetes prevalence, costs, and risk factors in Australia
- Obesity as a Risk Factor: Abdominal obesity and diabetes incidence from AusDiab
- Diet Quality and Blood Glucose: Longitudinal link between diet quality and glucose markers
- Metabolic Syndrome and Diabetes Prediction: Four metabolic syndrome definitions compared as diabetes predictors
- Interaction Between Diabetes Risk Factors: How obesity, diet, and metabolic syndrome interact
- Lifestyle and Pharmacist Interventions: Meta-analysis and pharmacy program outcomes for diabetes
- Conclusion: Summary of modifiable risk factors and intervention effectiveness
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Grounds every claim in specific empirical studies drawn from the AusDiab cohort, lending the analysis a consistent evidential thread throughout.
- Uses precise quantitative detail (relative risk values, p-values, sample sizes) to convey the strength and limitations of the evidence without overstating conclusions.
- Distinguishes clearly between risk-factor research and intervention research, helping the reader understand what the evidence can and cannot support.
Key academic technique demonstrated
The paper demonstrates effective evidence synthesis: rather than summarizing each study in isolation, it weaves findings from multiple AusDiab-based papers into a coherent narrative about how obesity, diet quality, and metabolic syndrome interact. The "Interaction Between Diabetes Risk Factors" section explicitly consolidates findings from preceding sections, modeling how a literature-based case study should build cumulative argument rather than merely list sources.
Structure breakdown
The paper opens with a brief epidemiological framing of type 2 diabetes in Australia, then dedicates one section each to three major risk factors (obesity, diet quality, metabolic syndrome). A synthesis section discusses how these factors interact before moving into two intervention types (lifestyle changes and pharmacy-based programs). The conclusion evaluates the relative effectiveness of interventions and notes gaps in the research. This risk-factor-then-intervention architecture is a standard and effective organizational pattern for public health case studies.
Introduction
Type 2 diabetes is by far the most common form of diabetes and is defined by glucose intolerance and elevated blood glucose levels (hyperglycaemia). Other physiological disorders frequently accompany diabetes, including dysregulation of lipid metabolism (dyslipidaemia), impaired kidney function, and cardiovascular disease, which contribute significantly to the morbidity and mortality suffered by patients (Barr, 2006, p. 6). Unfortunately, the cause of type 2 diabetes in most cases is not known (Barr, 2006, p. iii), but a number of risk factors have been identified that, if modified, can help improve outcomes.
Type 2 diabetes mellitus is the fastest growing chronic disease in Australia, with approximately 275 adults developing the disease each day (Barr et al., 2006, p. xi). At this rate, 0.8% of the population develops diabetes each year (Barr et al., 2006, p. 7). Current estimates suggest 1.7 million Australians have diabetes (Diabetes Australia – Vic), putting the overall prevalence rate near 8%. With the sixth highest mortality rate and an estimated cost to the healthcare system of nearly $4 billion in 2005 (Cameron et al., 2006), considerable investment in diabetes research and interventions is being made.
The risk factors for diabetes include being overweight (2-fold increased risk), obese (4-fold), physically inactive (2-fold), hypertensive (3-fold), dyslipidaemic (3-fold), and having metabolic syndrome (4-fold; Barr, 2006, pp. 9–12). Patients with diabetes were twice as likely to die during a five-year period — a mortality rate comparable to smokers and individuals suffering from cardiovascular disease (Barr, 2006, p. 42). A strong interaction between cardiovascular disease and diabetes was also revealed: over two-thirds of patients who died of cardiovascular disease also suffered from diabetes.
Obesity as a Risk Factor
Cameron et al. (2009) investigated the relationship between abdominal obesity and type 2 diabetes within the AusDiab Study cohort. A total of 6,072 men and women between the ages of 25 and 75 who had waist circumference data were included. Outcome measures after five years were type 2 diabetes, hypertension, dyslipidaemia, metabolic syndrome, and cardiovascular disease; mortality was assessed at eight years. Cameron et al. (2009) found that approximately 47.4% and 38.0% of the yearly incidence of diabetes is associated with obesity in women and men, respectively. This translates into a 3.3-fold and 3.6-fold increased risk compared to non-obese adults (p. 206).
Bibliography
Barr, E.L.M. et al. "AusDiab 2005: The Australian Diabetes, Obesity and Lifestyle Study. Tracking the Accelerating Epidemic: Its Causes and Outcomes." International Diabetes Institute, Melbourne, Australia (2006). Accessed May 2011.
Cameron, Adrian J. et al. (2008). "The Metabolic Syndrome as a Tool for Predicting Future Diabetes: The AusDiab Study." Journal of Internal Medicine 264: 177–186.
Cameron, Adrian J. et al. (2009). "Health and Mortality Consequences of Abdominal Obesity: Evidence from the AusDiab Study." Medical Journal of Australia 191: 202–208.
Cardona-Morrell, Magnolia et al. (2010). "Reduction of Diabetes Risk in Routine Clinical Practice: Are Physical Activity and Nutrition Interventions Feasible and Are the Outcomes from Reference Trials Replicable? A Systematic Review and Meta-Analysis." BMC Public Health 10: 653–669.
Diabetes Australia – Vic. "Diabetes Facts." Diabetes Australia – Vic website. Accessed May 2011.
Krass, I. et al. (2011). "Diabetes Medication Assistance Service Stage 1: Impact and Sustainability of Glycaemic and Lipids Control in Patients with Type 2 Diabetes." Diabetic Medicine (March 19): 1–18. Published online ahead of print.
McNaughton, Sara A. et al. (2009). "Dietary Quality is Associated with Diabetes and Cardio-Metabolic Risk Factors." Journal of Nutrition 139: 734–742.
Create your account
Always verify citation format against your institution’s current style guide requirements.